These are this morning’s top day trader and active trader alerts for Monday: Amazon.com, Inc. (NASDAQ: AMZN) is lower after Susquehanna cut its rating on fears of a competitive eReader market. Shares…
We are seeing many news-related movers in today’s edition of the BioHealth Business Daily. ACADIA Pharmaceuticals, Inc. (NASDAQ: ACAD), Adeona Pharmaceuticals, Inc. (AMEX: AEN), Dendreon Corporation (NASDAQ: DNDN), Exact Sciences Corp. (NASDAQ:…
Here are Wednesday’s top day trader and active trader alerts with more detailed trading volume and price analysis in the links over at VSInvestor.com: General Electric Co. (NYSE:GE) is challenging post-crash highs…
Diabetes is becoming an epidemic in the U.S. and the Western World. The ties to obesity are often direct, so the potential treatments are often directly tied as well. We did a…
The following are some of the top stocks to watch for active trading today based on pre-market and after-hours volume activity. There are links through to more detailed coverage and volume analysis…
These are this morning’s top day trading and active trader stocks on the move. We have also provided links through to more detailed price and volume analysis at VSInvestor.com: Human Genome Sciences…
Orexigen Therapeutics (OREX) Trouble with mid-stage drug trials. Drops to $1.55 from 52- week high of $15.63. Rf Microdevices (RFMD) Cuts guidance sharply. Falls to $.74 from 52-week high of $6. Berry…
(AAPL) Apple’s iTunes passed Amazon.com in music sales to become #3 music seller behind Best Buy and Wal-Mart.(AFOP) Alliance Fiber Optics raised Q2 sales guidance.(AGN) Allergan trades ex-split to reflect a 2-1…
Orexigen Therapeutics, Inc. (OREX-NASDAQ), a biopharmaceutical with an initial focus on obesity, has announced that data presented today at the American Diabetes Association 67th Scientific Sessions in Chicago from a sub-study of…
Douglas A. McIntyre ASML raised to Outperform at Bernstein.CENT cut to Neutral at B of A.COBZ raised to Outperform at KBW.DCP raised to Outperform at CIBC.DGX raised to Buy at UBS.ECL raised to Buy at…
